Home/Filings/4/0001214659-21-001480
4//SEC Filing

Schobel Alexander Mark 4

Accession 0001214659-21-001480

CIK 0001398733other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:00 PM ET

Size

4.8 KB

Accession

0001214659-21-001480

Insider Transaction Report

Form 4
Period: 2021-02-08
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
  • Sale

    Common Stock

    2021-02-08$6.50/sh40,792$265,148872,000 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001406836

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:00 PM ET
Size
4.8 KB